Table of Contents >> Show >> Hide
- What the Delaware Rapid Arbitration Act Was Built to Do
- Why Delaware Designed the DRAA This Way
- What Happened in OBI Pharma v. Biosion
- The Key Interpretation: Commencement Is Not the Same as the Award Clock
- How a DRAA Case Moves Once It Starts
- Why the Chancery Interpretation Matters to Drafting Lawyers
- Why Businesses May Like the DRAA
- Why Businesses Should Still Be Careful
- The Bigger Takeaway From Chancery
- Practical Experiences and Lessons From Rapid Arbitration
Delaware loves efficiency almost as much as corporate lawyers love a well-drafted dispute clause. That is part of what makes the Delaware Rapid Arbitration Act, or DRAA, so interesting. It is not ordinary arbitration with a fancier tie. It is a deliberately accelerated, contract-driven system built for sophisticated business disputes that need a real answer fast, not a leisurely procedural vacation.
The Delaware Court of Chancery’s 2025 decision in OBI Pharma, Inc. v. Biosion, Inc. gave this unusual statute a fresh dose of judicial attention. The ruling did not rewrite arbitration law from scratch, but it did something more useful for deal lawyers and litigators: it clarified how the DRAA’s machinery starts moving when the Court of Chancery appoints arbitrators. In a statute designed around speed, the starting gun matters.
That makes this decision worth more than a passing glance. The DRAA has existed since 2015, yet reported interpretations remain relatively rare. So when Chancery speaks, even in a short order, drafters should listen closely. The lesson from OBI Pharma is simple but important: under the DRAA, the difference between “the arbitration has commenced” and “the 120-day clock has started” is not semantic trivia. It is operational law.
What the Delaware Rapid Arbitration Act Was Built to Do
The DRAA was enacted to give Delaware business entities a prompt, cost-effective, and efficient way to resolve business disputes through voluntary arbitration before expert decision-makers. In plain English, Delaware wanted a process that cuts out delay tactics, narrows court involvement, and gets parties to a final award on a genuinely fast timetable.
But this is not a statute for everybody. The DRAA applies only if the parties satisfy specific entry conditions. There must be a written arbitration agreement. At least one party must be a Delaware business entity or have its principal place of business in Delaware. The agreement must say Delaware law governs or construes the clause. No party can be a consumer. And the agreement must expressly reference the “Delaware Rapid Arbitration Act.” That last point is not decorative drafting. If the clause does not say it, the DRAA is not invited to the party.
The statute also reflects Delaware’s strong freedom-of-contract culture. Parties that choose the DRAA are deemed to accept the Act’s procedural architecture, including the arbitrator’s authority to decide substantive and procedural arbitrability. They also waive several familiar litigation moves, including seeking to enjoin the arbitration, removing DRAA proceedings to federal court, and challenging interim rulings. In other words, once parties opt in, Delaware expects them to mean it.
Why Delaware Designed the DRAA This Way
The DRAA did not appear out of thin air. It arrived after Delaware’s earlier experiment with confidential judicial arbitration ran into constitutional trouble. That earlier model relied on sitting Chancery judges conducting private arbitrations in courthouses. The public-access concerns were obvious in hindsight, and the program did not survive. Delaware then retooled the concept.
The DRAA’s fix was elegant. Instead of using sitting judges as default arbitrators, the Act allows parties to choose their own arbitrators, and hearings need not take place in a Delaware courthouse at all. The result is a private arbitral system that preserves Delaware’s commercial-law expertise without blurring the line between a public courtroom proceeding and private dispute resolution. Think of it as Delaware learning from a prior draft and redlining aggressively.
What Happened in OBI Pharma v. Biosion
In OBI Pharma, the parties had an agreement requiring disputes to be arbitrated under the DRAA. The contract also called for a three-arbitrator panel, but it did not identify the arbitrators or specify a selection method. That is a small drafting omission with very large consequences once a dispute actually erupts.
After disputes arose and the contract’s pre-arbitration procedures ran their course, the petitioner asked the Court of Chancery to appoint the panel under Section 5805 of the Act. The respondent agreed to submit names for selection. The parties then jointly filed a list of six candidates, all apparently qualified under the statute. Chancellor McCormick appointed three respected retired Delaware jurists to serve as arbitrators.
So far, so procedural. But the important part came next. The Chancellor explained that the filing of the letter order itself “officially commences” the arbitration under DRAA Rule 9 when the Court of Chancery appoints the arbitrator or arbitrators. She also reminded the parties that the appointed arbitrators must file with the Court and serve on the parties a written notice of acceptance, including practical contact details and the form for written submissions. In a small but very human moment, the court waived the need for fax numbers. Delaware remains efficient, but not that nostalgic.
The Key Interpretation: Commencement Is Not the Same as the Award Clock
This is where the Chancery order becomes more than administrative housekeeping. Under DRAA Rule 9, when the Court appoints an arbitrator, the arbitration is commenced upon entry of the appointment order. But the Rule separately states that the statutory period for issuing a final award begins upon service of the written notice of acceptance by the arbitrator, or by the last arbitrator to accept in a multi-member panel.
That means two important things can be true at once. First, the arbitration formally exists once Chancery enters the appointment order. Second, the 120-day countdown to the final award does not begin until the acceptance notice is served. That distinction matters for scheduling, challenge calculations, pleading deadlines, and the overall discipline of a DRAA case.
In practice, OBI Pharma tells lawyers not to collapse these steps into one fuzzy event called “the arbitration started.” Under the DRAA, start-up procedure is segmented. Chancery can launch the proceeding. The arbitrators’ written acceptance triggers the award timeline. In a fast-track statute, that sequencing is not bureaucratic clutter. It is the traffic pattern.
How a DRAA Case Moves Once It Starts
Appointment and limited court involvement
The Court of Chancery has sharply limited jurisdiction under the DRAA. It may appoint arbitrators, enforce certain subpoenas at an arbitrator’s request, determine arbitrator fees, enter judgment in some circumstances, and issue an injunction in aid of arbitration only before an arbitrator accepts appointment. It cannot become a general-purpose supervisor of the arbitration. Delaware built the court’s role like a pit crew, not a backseat driver.
Compressed pleadings and scheduling
Once the arbitrator accepts, the rules move quickly. The claimant ordinarily must serve a complaint within two business days. The responding party typically has five business days to answer, subject to whatever limited flexibility the arbitrator allows. A preliminary conference usually should occur within ten calendar days of acceptance. That is not a schedule for the indecisive.
Discovery exists, but on a diet
The DRAA rules allow exchange of information necessary and appropriate to prepare for the hearing, but the system is not designed for sprawling discovery wars. Parties can agree to narrow or even forgo pre-hearing information exchange, subject to arbitrator approval. Dispositive motion practice is not automatic either; it happens only if the scheduling order allows it.
The hearing and final award
By default, the arbitration hearing is limited to one day unless the agreement says otherwise or the arbitrator determines that more time is warranted. The final award must generally issue within 120 days of acceptance, unless the agreement sets a different time or the parties unanimously extend the period by up to 60 additional days in the aggregate. If an arbitrator misses the deadline, fee consequences may follow. Delaware, in other words, did not create the DRAA for people who enjoy endless status reports.
Why the Chancery Interpretation Matters to Drafting Lawyers
The first drafting lesson is obvious: if parties want a DRAA panel, they should specify a workable selection process. In OBI Pharma, the parties still found a path forward because they cooperated enough to submit a joint candidate list. Not every dispute will feature that level of post-dispute civility. Some agreements would benefit from naming a selection method, a fallback institution, deadlines for nominations, and what happens if a party refuses to participate.
The second lesson is calendar discipline. Because commencement and acceptance are separate events under Rule 9, counsel should track both dates carefully. The court’s appointment order matters. The arbitrators’ acceptance notices matter. The last accepting arbitrator matters most in a three-member panel. Missing that nuance could lead to bad assumptions about pleading deadlines, hearing prep, or the final-award deadline.
The third lesson is to draft with remedy and review in mind. The DRAA gives arbitrators broad power to grant legal or equitable relief, and final awards receive only narrow review, generally aligned with Federal Arbitration Act standards. Agreements may also eliminate appellate review altogether or provide for appellate review before arbitrators instead of the Delaware Supreme Court. Parties should decide that structure when the deal is friendly, not after the relationship catches fire.
Why Businesses May Like the DRAA
For the right dispute, the DRAA is attractive. It is private. It is fast. It permits expert arbitrators. It keeps court interference narrow. And it offers Delaware-law credibility in transactions where Delaware entities are already part of the architecture. That combination makes particular sense for M&A disputes, licensing fights, joint venture fallouts, governance conflicts among sophisticated parties, and other matters where speed has real economic value.
There is also a more subtle benefit. The DRAA forces prioritization. Because the timetable is tight, parties have less room for performative litigation theater. The process rewards focused pleadings, concentrated evidence, and smart issue selection. For clients who want resolution instead of a three-ring discovery circus, that can be refreshing.
Why Businesses Should Still Be Careful
Fast is not automatically better. The DRAA may be a poor fit for cases that genuinely require broad third-party discovery, extensive motion practice, or a longer factual record. It can also become awkward when the contract clause is half-finished, especially on arbitrator selection, seat issues, hearing logistics, confidentiality protocols, or appellate design.
And while limited review is often a selling point, it is also a risk. Parties choosing the DRAA are largely choosing finality. That is wonderful when you win and less poetic when you do not.
The Bigger Takeaway From Chancery
The 2025 Chancery order in OBI Pharma does not transform the DRAA, but it does sharpen it. The court confirmed that when Chancery appoints arbitrators under Section 5805, the appointment order officially commences the arbitration under Rule 9. At the same time, the arbitrators’ written acceptance remains essential because it starts the clock for the final award and establishes the practical channels for the case to proceed.
That is classic Delaware commercial law: not flashy, but precise. The court took a sparse statutory framework and made its operation more concrete. For lawyers who draft arbitration clauses and for parties who may someday live inside one, precision like that is gold.
If the DRAA gains broader use in the years ahead, OBI Pharma may be remembered as one of the early decisions that helped explain how Delaware’s rapid-arbitration engine actually turns over. The message is straightforward. Under the DRAA, speed is contractual, procedure matters, and the launch sequence is not optional reading.
Practical Experiences and Lessons From Rapid Arbitration
Parties who use fast-track arbitration systems like the DRAA often discover the same thing in the first two weeks: the process is only as smooth as the clause that created it. A beautifully negotiated acquisition agreement can still contain a sleepy dispute provision drafted at 11:47 p.m. on signing night. Then a real dispute hits, and everyone suddenly realizes the clause says “three arbitrators” but not how on earth they get selected. That is exactly why the Chancery guidance in OBI Pharma matters. The statute is speedy, but it still needs a runway.
Another common experience is that business clients initially love the idea of a 120-day path to a final award, right up until they understand what 120 days feels like in real life. It feels like documents must be organized now. It feels like witnesses must be identified now. It feels like outside counsel cannot spend six weeks debating custodians while the merits wait politely in the hallway. Rapid arbitration has a way of exposing whether a party truly wants resolution or merely enjoys the motivational posters about efficiency.
There is also a cultural shift. In ordinary litigation, some lawyers treat motion practice like a hobby. Under the DRAA, that hobby gets expensive fast. The rules push the parties toward focused pleadings, practical scheduling, and a hearing that is often measured in hours, not seasons. Clients sometimes find that surprisingly refreshing. Others find it mildly terrifying. Both reactions are understandable.
From a strategic standpoint, parties also learn that arbitrator selection is not a side quest. In a rapid system, the arbitrator’s management style can shape the entire case. A commercially savvy arbitrator who understands valuation, licensing, biotech milestones, governance fights, or post-closing accounting disputes can compress complexity without flattening it. A poor fit can turn “rapid” into “chaotic.” The DRAA’s emphasis on expert arbitrators is one of its real strengths, but only if the parties treat selection with the seriousness it deserves.
Finally, there is the emotional experience of finality. DRAA proceedings are designed to reach an endpoint quickly and with limited review. That can be a tremendous advantage for companies that need certainty for operations, financing, reporting, or deal integration. But it also means the parties must be psychologically prepared for a process where there are fewer procedural cushions and fewer second chances. The DRAA is not a casual promise. It is a deliberate trade: less delay, less theater, and often less room for regret.
For companies that understand those tradeoffs, Delaware’s rapid-arbitration framework can be a remarkably sophisticated tool. For companies that do not, it can feel like boarding a bullet train after packing for a cruise.
